Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
55.50    -0.50 (-0.89%)
Bid:
55.00
Ask:
56.00
Spread: 1.00 (1.818%)
Market Cap: £8.45m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Trading Update

18 Jul 2016 07:01

RNS Number : 3909E
Transense Technologies PLC
18 July 2016
 

18 July 2016

Transense Technologies Plc

("Transense" or "the Company")

Trading Update

Transense Technologies Plc (AIM: TRT), the provider of sensor systems for the transportation and industrial markets, provides a trading update relating to the financial year ended 30 June 2016.

Trading update

The company reported that the sale of IntelliSaw to Emerson in October 2015, with the associated limited scope licensing of core Surface Acoustic Wave ("SAW") sensor technology, provided a strong signal to the industrial marketplace of the increasing maturity and value of this expertise. Progress towards commercialisation of SAW across several other applications has been steady throughout the second half of the year. This has become evident through the successful product launch by a major European customer in April 2016, and the post year-end signing of a licensing agreement in partnership with GE announced today. In the short term, SAW revenue generation is not a key value driver, however the board are pleased to note that sales for the full year did finish broadly in line with expectations.

The rate of revenue growth in Translogik continues to be held back by difficult market conditions in the mining sector. Several live trials are in progress and demonstrating good results, but decision making timescales continue to be elongated by financial and other constraints. Meanwhile, there has been an upturn in the rate of sales of tyre probe products in the second half of the year, which is encouraging.

Overall, trading results for the year ended 30 June 2016 are expected to be in line with the board's expectations as revised on the release of the interim results in March, with revenues of approximately £2M, and closing cash balances of £3.6M.

 

Capital structure

The board has taken advice on steps which may be taken to eliminate the accumulated deficit on reserves through a capital restructuring exercise and intends to bring proposals forward at the Annual General Meeting later this year.

 

 

For further information please visit www.transense.co.uk or contact:

 

Transense Technologies Plc

Graham Storey, Chief Executive

 

Tel: +44 (0) 1869 238380

 

finnCap

Ed Frisby, Giles Rolls (Corporate Finance)

Tony Quirke, Alice Lane (Corporate Broking)

 

Tel: +44 (0) 20 7220 0500

 

IFC Advisory

Tim Metcalfe, Graham Herring, Heather Armstrong

 

Tel: +44 (0) 20 3053 8671

 

 

 

About Transense Technologies

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. Transense's Surface Acoustic Wave (SAW), wireless, battery-less, sensor systems offer significant advantages over legacy wireless sensor systems. Transense is targeting the transport and mining industries, and the global torque, temperature and pressure sensing markets, via its trading divisions, Translogik and SAWSense.

Transense's shares are admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT).

www.transense.co.uk

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTAKODNFBKDPOD
Date   Source Headline
1st Apr 20193:02 pmRNSResult of General Meeting
22nd Mar 201910:30 amRNSHolding(s) in Company
20th Mar 201910:02 amRNSHolding(s) in Company
15th Mar 20199:33 amRNSNotice of GM and Posting of Circular
14th Mar 20193:30 pmRNSEIS Advance Assurance and Total Voting Rights
13th Mar 20193:35 pmRNSInterim Results
13th Mar 20193:35 pmRNSPlacing & General Meeting
22nd Feb 20198:36 amRNSHolding(s) in Company
20th Feb 20198:30 amRNSiTrack Contract Win
18th Feb 20197:00 amRNSSignificant iTrack Order
4th Feb 20197:00 amRNSGE Aviation Contract Win
21st Dec 20181:22 pmRNSResult of AGM
21st Dec 20187:00 amRNSAGM Statement
21st Nov 20187:00 amRNSNotice of AGM
12th Nov 20187:00 amRNSTranslogik iTrack Contract Win in new Territory
9th Oct 20187:00 amRNSFinal Results
26th Sep 20187:00 amRNSNotice of Results
23rd Aug 20182:44 pmRNSHolding(s) in Company
1st Aug 20187:00 amRNSTrading Update
25th Jun 20188:29 amRNSHolding(s) in Company
21st Jun 20182:33 pmRNSResult of General Meeting
31st May 20187:00 amRNSPlacing and Notice of General Meeting
8th May 20187:00 amRNSNew Translogik iTrack Contract Win
2nd Mar 201812:26 pmRNSStatement re joint broker
7th Feb 20187:00 amRNSInterim Results
5th Feb 20189:56 amRNSHolding(s) in Company
21st Dec 20171:09 pmRNSResult of AGM
21st Dec 20177:00 amRNSAGM Statement
18th Dec 201711:18 amRNSIssue of Equity
27th Nov 20179:29 amRNSContract Win
14th Nov 20177:00 amRNSNotice of AGM
26th Sep 20177:00 amRNSFinal Results
5th Sep 20177:00 amRNSNotice of Results
5th Sep 20177:00 amRNSInvestor Event
7th Aug 20177:00 amRNSNew iTrack Contract Win with BHP in Australia
31st Jul 20177:00 amRNSTrading Update
27th Jun 20177:00 amRNSAward of options
26th Jun 20177:00 amRNSGlencore - Further Contract Win
6th Jun 20177:00 amRNSDirector/PDMR Shareholding
5th Jun 20177:00 amRNSGlencore - Further Contract Win
4th Apr 20175:20 pmRNSHolding(s) in Company
29th Mar 20177:01 amRNSInterim results
29th Mar 20177:00 amRNSFurther Payment from General Electric
1st Mar 20177:00 amRNSInvestor Event
28th Feb 20171:54 pmRNSNotice of Results
27th Jan 20177:00 amRNSIssue of Equity
22nd Dec 20168:19 amRNSCapital Reduction
23rd Nov 20163:45 pmRNSResult of AGM & Share Consolidation
23rd Nov 20167:00 amRNSAGM Statement
21st Sep 20167:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.